Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate.
Sharma
S
S
Cobbold Laboratories, UCL Medical School, Middlesex Hospital, London, UK.
Jacobs
H S
HS
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006801:Humans; D011085:Polycystic Ovary Syndrome / Q000139:chemically induced* / Q000503:physiopathology; D011247:Pregnancy; D014635:Valproic Acid / Q000009:adverse effects* / Q000627:therapeutic use; D015430:Weight Gain / Q000502:physiology
D000927:Anticonvulsants; D014635:Valproic Acid